Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS).

Next Previous
Trial Profile

An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS).

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Decitabine (Primary)
  • Indications Myelodysplastic syndromes
  • Focus Adverse reactions; Expanded access
  • Sponsors Janssen-Cilag

    • Most Recent Events

    • 17 Apr 2013 Actual initiation date changed from May 2008 to Jun 2008 as reported by ClinicalTrials.gov.
    • 25 Jun 2012 Planned snd date changed from 1 Dec 2013 to 1 Nov 2011 as reported by ClinicalTrials.gov.
    • 23 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top